Conditions: Anemia
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 735
Healthy volunteers: no

Brief summary:
The objective of this study is to evaluate the safety of FCM in patients with anemia who are not dialysis dependent

Detailed description:

Arms:
arm 1: 15 mg/kg up to a maximum of 750 mg at 100 mg/minute intravenously on Day 0. arm 2: Per product label

Interventions: intervention 1: Ferric Carboxymaltose intervention 2: Standard Medical Care (SMC)
Intervention descriptions: intervention 1: 15 mg/kg up to a maximum of 750 mg at 100 mg/minute intravenously on Day 0. intervention 2: Per product label

Protocol document: